OxyContin maker Purdue Pharma has received a patent to treat opioid addiction: report
In September, the Financial Times reported that Purdue Pharma had received a patent to treat opioid addiction. Essentially this means that the very organization responsible for our current opioid crisis would now be helping to end it. But before you get all teary-eyed thinking about how altruistic it sounds, don’t. Because money. Lots and lots of money. “The patent is for a new version of buprenorphine, which is designed to control drug cravings and is often given to those who are addicted to heroin or opioid painkillers. The patent is reportedly for a “wafer” of the drug, which would dissolve...
Read More






